Skip to main content

Neuromodulation for Chronic Pelvic Pain

  • Chapter
  • First Online:
Adult and Pediatric Neuromodulation

Abstract

Chronic pelvic pain, a complex condition defined by non-malignant pain of the pelvic musculature or viscera often with associated hyperalgesia, is difficult to treat. The pathophysiology can be hard to delineate, as pelvic innervation involves the sympathetic, parasympathetic, and somatic nervous systems. However, dysregulated central nervous system responses to non-noxious stimuli are likely the major underlying factor.

Given this proposed etiology, some clinicians offer sacral neuromodulation as part of a multimodal approach to this condition, believing that neuromodulation can restore the balance between excitatory and inhibitory impulses to and from the pelvic organs at the levels of the sacral and suprasacral spinal cord. Studies have demonstrated improvement in pain in some patients, though these are mostly small and non-randomized, making generalization difficult. Controversy remains regarding the best approach, including which pelvic nerves to target and whether bilateral stimulation offers better results than unilateral stimulation. Large-scale randomized trials with long term follow up and clearly stated, strict inclusion criteria are needed in order to more thoroughly evaluate SNS as a treatment for chronic pelvic pain.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hunter C, Dave N, Diwan S, Deer T. Neuromodulation of pelvic visceral pain: review of the literature and case series of potential novel targets for treatment. Pain Pract. 2013;13(1):3–17.

    Article  PubMed  Google Scholar 

  2. Kothari S. Neuromodulatory approaches to chronic pelvic pain and coccygodynia. Acta Neurochir Suppl. 2007;97(Pt 1):365–71.

    CAS  PubMed  Google Scholar 

  3. Fariello JY, Whitmore K. Sacral neuromodulation stimulation for IC/PBS, chronic pelvic pain, and sexual dysfunction. Int Urogynecol J. 2010;21(12):1553–8.

    Article  PubMed  Google Scholar 

  4. Mathias SD, Kuppermann M, Liberman RF, Lipschutz RC, Steege JF. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol. 1996;87(3):321–7.

    Article  CAS  PubMed  Google Scholar 

  5. Lampe A, Solder E, Ennemoser A, Schubert C, Rumpold G, Sollner W. Chronic pelvic pain and previous sexual abuse. Obstet Gynecol. 2000;96(6):929–33.

    CAS  PubMed  Google Scholar 

  6. Heim C, Ehlert U, Hanker JP, Hellhammer DH. Abuse-related posttraumatic stress disorder and alterations of the hypothalamic-pituitary-adrenal axis in women with chronic pelvic pain. Psychosom Med. 1998;60(3):309–18.

    Article  CAS  PubMed  Google Scholar 

  7. Martinez-Lavin M. Is fibromyalgia a generalized reflex sympathetic dystrophy? Clin Exp Rheumatol. 2001;19(1):1–3.

    CAS  PubMed  Google Scholar 

  8. Longstreth GF. Irritable bowel syndrome and chronic pelvic pain. Obstet Gynecol Surv. 1994;49(7):505–7.

    Article  CAS  PubMed  Google Scholar 

  9. de la Rosette JJ, Hubregtse MR, Meuleman EJ, Stolk-Engelaar MV, Debruyne FM. Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology. 1993;41(4):301–7.

    Article  PubMed  Google Scholar 

  10. Krieger JN, Nyberg L Jr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;282(3):236–7.

    Article  CAS  PubMed  Google Scholar 

  11. Raj P. Practical management of pain. St. Louis, MO: Mosby Inc.; 2000.

    Google Scholar 

  12. Janicki TI. Chronic pelvic pain as a form of complex regional pain syndrome. Clin Obstet Gynecol. 2003;46(4):797–803.

    Article  PubMed  Google Scholar 

  13. Comiter CV. Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. J Urol. 2003;169(4):1369–73.

    Article  PubMed  Google Scholar 

  14. Prevalence of interstitial cystitis/painful bladder syndrome in the United States: The RAND Interstitial Cystitis Epidemiology study. Annual Meeting of the American Urological Association; 2009.

    Google Scholar 

  15. Nazif O, Teichman JM, Gebhart GF. Neural upregulation in interstitial cystitis. Urology. 2007;69(4 Suppl):24–33.

    Article  PubMed  Google Scholar 

  16. Hanno P, Burks D, Clemens J, Dmochowski R, Erickson D, et al. Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome. 2014. https://www.auanet.org/common/pdf/education/clinical-guidance/IC-Bladder-Pain-Syndrome-Revised.pdf. Accessed 11 Nov 2016.

  17. Carrico DJ, Peters KM, Diokno AC. Guided imagery for women with interstitial cystitis: results of a prospective, randomized controlled pilot study. J Altern Complement Med. 2008;14(1):53–60.

    Article  PubMed  Google Scholar 

  18. Foster HE Jr, Hanno PM, Nickel JC, Payne CK, Mayer RD, Burks DA, et al. Effect of amitriptyline on symptoms in treatment naive patients with interstitial cystitis/painful bladder syndrome. J Urol. 2010;183(5):1853–8.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Hsieh TF, KJ Y, Lin SY. Possible application of Raman microspectroscopy to verify the interstitial cystitis diagnosis after potassium sensitivity test: phenylalanine or tryptophan as a biomarker. Dis Markers. 2007;23(3):147–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Herati AS, Shorter B, Srinivasan AK, Tai J, Seideman C, Lesser M, et al. Effects of foods and beverages on the symptoms of chronic prostatitis/chronic pelvic pain syndrome. Urology. 2013;82(6):1376–80.

    Article  PubMed  Google Scholar 

  21. Peters KM, Carrico DJ, Kalinowski SE, Ibrahim IA, Diokno AC. Prevalence of pelvic floor dysfunction in patients with interstitial cystitis. Urology. 2007;70(1):16–8.

    Article  PubMed  Google Scholar 

  22. Weiss JM. Pelvic floor myofascial trigger points: manual therapy for interstitial cystitis and the urgency-frequency syndrome. J Urol. 2001;166(6):2226–31.

    Article  CAS  PubMed  Google Scholar 

  23. Anderson RU, Wise D, Sawyer T, Chan C. Integration of myofascial trigger point release and paradoxical relaxation training treatment of chronic pelvic pain in men. J Urol. 2005;174(1):155–60.

    Article  PubMed  Google Scholar 

  24. FitzGerald MP, Anderson RU, Potts J, Payne CK, Peters KM, Clemens JQ, et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol. 2009;182(2):570–80.

    Article  PubMed  PubMed Central  Google Scholar 

  25. FitzGerald MP, Payne CK, Lukacz ES, Yang CC, Peters KM, Chai TC, et al. Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. J Urol. 2012;187(6):2113–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. van Ophoven A, Pokupic S, Heinecke A, Hertle L. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol. 2004;172(2):533–6.

    Article  PubMed  Google Scholar 

  27. Thilagarajah R, Witherow RO, Walker MM. Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial. BJU Int. 2001;87(3):207–12.

    Article  CAS  PubMed  Google Scholar 

  28. Dasgupta P, Sharma SD, Womack C, Blackford HN, Dennis P. Cimetidine in painful bladder syndrome: a histopathological study. BJU Int. 2001;88(3):183–6.

    Article  CAS  PubMed  Google Scholar 

  29. Seshadri P, Emerson L, Morales A. Cimetidine in the treatment of interstitial cystitis. Urology. 1994;44(4):614–6.

    Article  CAS  PubMed  Google Scholar 

  30. Theoharides TC, Sant GR. Hydroxyzine therapy for interstitial cystitis. Urology. 1997;49(5A Suppl):108–10.

    Article  CAS  PubMed  Google Scholar 

  31. Sant GR, Propert KJ, Hanno PM, Burks D, Culkin D, Diokno AC, et al. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol. 2003;170(3):810–5.

    Article  CAS  PubMed  Google Scholar 

  32. Theoharides TC. Hydroxyzine in the treatment of interstitial cystitis. Urol Clin North Am. 1994;21(1):113–9.

    CAS  PubMed  Google Scholar 

  33. Colaco MA, Evans RJ. Current recommendations for bladder instillation therapy in the treatment of interstitial cystitis/bladder pain syndrome. Curr Urol Rep. 2013;14(5):442–7.

    Article  PubMed  Google Scholar 

  34. Nickel JC, Jain P, Shore N, Anderson J, Giesing D, Lee H, et al. Continuous intravesical lidocaine treatment for interstitial cystitis/bladder pain syndrome: safety and efficacy of a new drug delivery device. Sci Transl Med. 2012;4(143):143ra100.

    Article  CAS  PubMed  Google Scholar 

  35. Cole EE, Scarpero HM, Dmochowski RR. Are patient symptoms predictive of the diagnostic and/or therapeutic value of hydrodistention? Neurourol Urodyn. 2005;24(7):638–42.

    Article  PubMed  Google Scholar 

  36. Erickson DR, Kunselman AR, Bentley CM, Peters KM, Rovner ES, Demers LM, et al. Changes in urine markers and symptoms after bladder distention for interstitial cystitis. J Urol. 2007;177(2):556–60.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Ottem DP, Teichman JM. What is the value of cystoscopy with hydrodistension for interstitial cystitis? Urology. 2005;66(3):494–9.

    Article  PubMed  Google Scholar 

  38. Kuo HC, Chancellor MB. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome. BJU Int. 2009;104(5):657–61.

    Article  CAS  PubMed  Google Scholar 

  39. Pinto R, Lopes T, Frias B, Silva A, Silva JA, Silva CM, et al. Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. Eur Urol. 2010;58(3):360–5.

    Article  CAS  PubMed  Google Scholar 

  40. Gajewski JB, Al-Zahrani AA. The long-term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centre. BJU Int. 2011;107(8):1258–64.

    Article  PubMed  Google Scholar 

  41. Ghazwani YQ, Elkelini MS, Hassouna MM. Efficacy of sacral neuromodulation in treatment of bladder pain syndrome: long-term follow-up. Neurourol Urodyn. 2011;30(7):1271–5.

    PubMed  Google Scholar 

  42. Marinkovic SP, Gillen LM, Marinkovic CM. Minimum 6-year outcomes for interstitial cystitis treated with sacral neuromodulation. Int Urogynecol J. 2011;22(4):407–12.

    Article  PubMed  Google Scholar 

  43. Powell CR, Kreder KJ. Long-term outcomes of urgency-frequency syndrome due to painful bladder syndrome treated with sacral neuromodulation and analysis of failures. J Urol. 2010;183(1):173–6.

    Article  PubMed  Google Scholar 

  44. Sairanen J, Tammela TL, Leppilahti M, Multanen M, Paananen I, Lehtoranta K, et al. Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. J Urol. 2005;174(6):2235–8.

    Article  CAS  PubMed  Google Scholar 

  45. Forrest JB, Payne CK, Erickson DR. Cyclosporine A for refractory interstitial cystitis/bladder pain syndrome: experience of 3 tertiary centers. J Urol. 2012;188(4):1186–91.

    Article  CAS  PubMed  Google Scholar 

  46. Rossberger J, Fall M, Jonsson O, Peeker R. Long-term results of reconstructive surgery in patients with bladder pain syndrome/interstitial cystitis: subtyping is imperative. Urology. 2007;70(4):638–42.

    Article  PubMed  Google Scholar 

  47. Madersbacher H. Conservative therapy of neurogenic disorders of micturition. Urologe A. 1999;38(1):24–9.

    Article  CAS  PubMed  Google Scholar 

  48. Nashold BS Jr, Friedman H, Boyarsky S. Electrical activation of micturition by spinal cord stimulation. J Surg Res. 1971;11(3):144–7.

    Article  PubMed  Google Scholar 

  49. Van Kerrebroeck PE. Advances in the role of sacral nerve neuromodulation in lower urinary tract symptoms. Int Urogynecol J. 2010;21(Suppl 2):S467–74.

    Article  PubMed  Google Scholar 

  50. Mayer R, Howard F. Sacral nerve stimultation: neuromodulation for voiding dysfunction and pain. Neurotherapeutics. 2008;5:107–13.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Dasgupta R, Critchley HD, Dolan RJ, Fowler CJ. Changes in brain activity following sacral neuromodulation for urinary retention. J Urol. 2005;174(6):2268–72.

    Article  PubMed  Google Scholar 

  52. Zabihi N, Mourtzinos A, Maher MG, Raz S, Rodriguez LV. Short-term results of bilateral S2-S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful bladder syndrome, and chronic pelvic pain. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(4):553–7.

    Article  PubMed  Google Scholar 

  53. Fall M, Baranowski AP, Elneil S, Engeler D, Hughes J, Messelink EJ, et al. EAU guidelines on chronic pelvic pain. Eur Urol. 2010;57(1):35–48.

    Article  PubMed  Google Scholar 

  54. Melzack R, Wall P. Pain mechanisms: a new theory. Science. 1965;150:971.

    Article  CAS  Google Scholar 

  55. van der Pal F, Heesakkers JP, Bemelmans BL. Current opinion on the working mechanisms of neuromodulation in the treatment of lower urinary tract dysfunction. Curr Opin Urol. 2006;16(4):261–7.

    Article  PubMed  Google Scholar 

  56. Marcelissen T, Jacobs R, van Kerrebroeck P, de Wachter S. Sacral neuromodulation as a treatment for chronic pelvic pain. J Urol. 2011;186(2):387–93.

    Article  CAS  Google Scholar 

  57. Hohenfellner M, Dahms SE, Matzel K, Thuroff JW. Sacral neuromodulation for treatment of lower urinary tract dysfunction. BJU Int. 2000;85(Suppl 3):10–9; discussion 22–3.

    Article  PubMed  Google Scholar 

  58. Maher CF, Carey MP, Dwyer PL, Schluter PL. Percutaneous sacral nerve root neuromodulation for intractable interstitial cystitis. J Urol. 2001;165(3):884–6.

    Article  CAS  PubMed  Google Scholar 

  59. Siegel S, Paszkiewicz E, Kirkpatrick C, Hinkel B, Oleson K. Sacral nerve stimulation in patients with chronic intractable pelvic pain. J Urol. 2001;166(5):1742–5.

    Article  CAS  PubMed  Google Scholar 

  60. Brookoff D, Bennett D. Neuromodulation in intractable interstitial cystitis and related pain syndromes. Pain Med. 2006;7(suppl 1):S166–84.

    Article  Google Scholar 

  61. Everaert K, Plancke H, Lefevere F, Oosterlinck W. The urodynamic evaluation of neuromodulation in patients with voiding dysfunction. Br J Urol. 1997;79(5):702–7.

    Article  CAS  PubMed  Google Scholar 

  62. Whitmore KE, Payne CK, Diokno AC, Lukban JC. Sacral neuromodulation in patients with interstitial cystitis: a multicenter clinical trial. Int Urogynecol J Pelvic Floor Dysfunct. 2003;14(5):305–8; discussion 308–9.

    Article  PubMed  Google Scholar 

  63. Peters KM, Konstandt D. Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitis. BJU Int. 2004;93(6):777–9.

    Article  CAS  PubMed  Google Scholar 

  64. Rackley R, Vasavada S, Daneshgari F. Neuromodulation for interstitial cystitis. Cleveland Clinic Glickman Urologic Institute. 2005. https://my.clevelandclinic.org/ccf/media/files/Urology/AUA%20Abstracts%202005.pdf.

  65. Steinberg AC, Oyama IA, Whitmore KE. Bilateral S3 stimulator in patients with interstitial cystitis. Urology. 2007;69(3):441–3.

    Article  PubMed  Google Scholar 

  66. Kim SW, Paick JS, Ku JH. Percutaneous posterior tibial nerve stimulation in patients with chronic pelvic pain: a preliminary study. Urol Int. 2007;78(1):58–62.

    Article  PubMed  Google Scholar 

  67. van Balken MR, Vandoninck V, Messelink BJ, Vergunst H, Heesakkers JP, Debruyne FM, et al. Percutaneous tibial nerve stimulation as neuromodulative treatment of chronic pelvic pain. Eur Urol. 2003;43(2):158–63; discussion 163.

    Article  PubMed  Google Scholar 

  68. Peters KM, Killinger KA, Boguslawski BM, Boura JA. Chronic pudendal neuromodulation: expanding available treatment options for refractory urologic symptoms. Neurourol Urodyn. 2010;29(7):1267–71.

    Article  PubMed  Google Scholar 

  69. Heinze K, Hoermann R, Fritsch H, Dermietzel R, van Ophoven A. Comparative pilot study of implantation techniques for pudendal neuromodulation: technical and clinical outcome in first 20 patients with chronic pelvic pain. World J Urol. 2015;33(2):289–94.

    Article  CAS  PubMed  Google Scholar 

  70. Peters KM, Feber KM, Bennett RC. A prospective, single-blind, randomized crossover trial of sacral vs pudendal nerve stimulation for interstitial cystitis. BJU Int. 2007;100(4):835–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Courtenay K. Moore .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lloyd, J.C., Moore, C.K. (2018). Neuromodulation for Chronic Pelvic Pain. In: Gilleran, J., Alpert, S. (eds) Adult and Pediatric Neuromodulation . Springer, Cham. https://doi.org/10.1007/978-3-319-73266-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-73266-4_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-73265-7

  • Online ISBN: 978-3-319-73266-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics